Maternal separation differentially modulates early pathology by sex in 5xFAD Alzheimer’s disease-transgenic mice

Maternal separation differentially modulates early pathology by sex in 5xFAD Alzheimer’s disease-transgenic mice

Alzheimer’s disease (AD) is the most common neurodegenerative disease. Most cases of AD are considered idiopathic and likely due to a combination of genetic, environmental, and lifestyle-related risk factors. Despite occurring decades before the typical age of an AD diagnosis, early-life stress (ELS...

Full description

Bibliographic Details
Main Authors:	M.G. Garcia, A. Paulus, S. Vázquez-Reyes, O. Klementieva, G.K. Gouras, S. Bachiller, T. Deierborg
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Brain, Behavior, & Immunity - Health
Subjects:	Alzheimer’s disease Early-life stress Maternal separation Neuroinflammation Amyloid-β
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666354623000777

Similar Items

RETRACTED ARTICLE: Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer’s disease
by: Panchanan Maiti, et al.
Published: (2018-02-01)

Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease
by: Leela Paladugu, et al.
Published: (2021-01-01)

Dexmedetomidine exerts an anti-inflammatory effect via α2 adrenoceptors to alleviate cognitive dysfunction in 5xFAD mice
by: Su-mei Luo, et al.
Published: (2022-09-01)

Impact of the Age of Cecal Material Transfer Donors on Alzheimer’s Disease Pathology in 5xFAD Mice
by: Francesco Valeri, et al.
Published: (2021-12-01)

(-)-Oleocanthal Nutraceuticals for Alzheimer’s Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model
by: Afsana Tajmim, et al.
Published: (2021-05-01)

Sleep fragmentation affects glymphatic system through the different expression of AQP4 in wild type and 5xFAD mouse models
by: Valeria Vasciaveo, et al.
Published: (2023-01-01)

Therapeutic Effects of Aβ-Specific Regulatory T Cells in Alzheimer’s Disease: A Study in 5xFAD Mice
by: Seon-Young Park, et al.
Published: (2024-01-01)

Phytohormone Abscisic Acid Improves Memory Impairment and Reduces Neuroinflammation in 5xFAD Mice by Upregulation of LanC-Like Protein 2
by: Seung Ho Jeon, et al.
Published: (2020-11-01)

Sex Differences between Neuronal Loss and the Early Onset of Amyloid Deposits and Behavioral Consequences in 5xFAD Transgenic Mouse as a Model for Alzheimer’s Disease
by: Chi Him Poon, et al.
Published: (2023-03-01)

The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer’s Disease
by: Anna E. Bugrova, et al.
Published: (2021-12-01)

Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals
by: R. Mabrouk, et al.
Published: (2023-06-01)

Phyllodulcin improves hippocampal long-term potentiation in 5XFAD mice
by: Eunbi Cho, et al.
Published: (2023-05-01)

Neuroprotective properties of anti-apoptotic BCL-2 proteins in 5xFAD mouse model of Alzheimer’s disease
by: D. Chernyuk, et al.
Published: (2023-06-01)

Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice
by: Dorit Farfara, et al.
Published: (2023-07-01)

Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease
by: Agnes Paulus, et al.
Published: (2021-03-01)

Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
by: Tasha R. Womack, et al.
Published: (2022-02-01)

Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice
by: Dina Medina-Vera, et al.
Published: (2023-10-01)

Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer’s Mice
by: Henning Johannes Drews, et al.
Published: (2021-02-01)

Autosomal Dominant Alzheimer’s Disease Mutations in Human Microglia Are Not Sufficient to Trigger Amyloid Pathology in WT Mice but Might Affect Pathology in 5XFAD Mice
by: Carmen Romero-Molina, et al.
Published: (2024-02-01)

Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease
by: Karthivashan Govindarajan, et al.
Published: (2023-07-01)

Impact of Gut Microbiome Manipulation in 5xFAD Mice on Alzheimer’s Disease-Like Pathology
by: Malena dos Santos Guilherme, et al.
Published: (2021-04-01)

A Transgenic 5xFAD-M Line of Mice for Dendritic Spine Morphology Analysis in Alzheimer’s Disease
by: Anastasiia Ilina, et al.
Published: (2023-02-01)

Attenuation of Alzheimer’s brain pathology in 5XFAD mice by PTH1-34, a peptide of parathyroid hormone
by: Li Chen, et al.
Published: (2023-03-01)

Whole-body vibration ameliorates glial pathological changes in the hippocampus of hAPP transgenic mice, but does not affect plaque load
by: Tamas Oroszi, et al.
Published: (2023-03-01)

Secondary Modification of S100B Influences Anti Amyloid-β Aggregation Activity and Alzheimer’s Disease Pathology
by: Romina Coelho, et al.
Published: (2024-02-01)

Second Wave, Late-Stage Neuroinflammation in Cleared Brains of Aged 5xFAD Alzheimer’s Mice Detected by Macrolaser Light Sheet Microscopy Imaging
by: Suk Hyun Lee, et al.
Published: (2023-12-01)

Cyclopentanone Derivative Attenuates Memory Impairment by Inhibiting Amyloid Plaques Formation in the 5xFAD Mice
by: Rahim Ullah, et al.
Published: (2021-09-01)

Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer’s disease in APP/PS1 mouse
by: Shang Wang, et al.
Published: (2023-02-01)

The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer’s disease pathology models
by: Megan J. Lantz, et al.
Published: (2023-05-01)

Oral Administration of Probiotic Bacteria Alleviates Tau Phosphorylation, Aβ Accumulation, Microglia Activation, and Memory Loss in 5xFAD Mice
by: Yeong Jin Kim, et al.
Published: (2024-02-01)

Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer’s Disease Pathology in 5xFAD Model Mice
by: Malena dos Santos Guilherme, et al.
Published: (2020-08-01)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
by: Rosalía Fernández-Calle, et al.
Published: (2022-09-01)

Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
by: Hoda M. Gebril, et al.
Published: (2024-01-01)

Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model
by: Ye Ji Jeong, et al.
Published: (2021-08-01)

A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease
by: Annett Boeddrich, et al.
Published: (2023-07-01)

Alzheimer’s Disease Research Using Human Microglia
by: Lih-Fen Lue, et al.
Published: (2019-08-01)

Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ
by: Kyung Won Jo, et al.
Published: (2022-10-01)

Oral Administration of <i>Euonymus alatus</i> Leaf Extract Ameliorates Alzheimer’s Disease Phenotypes in 5xFAD Transgenic Mice
by: Yoonsu Kim, et al.
Published: (2024-02-01)

Long-Term Administration of <i>Vespa velutina nigrithorax</i> Venom Ameliorates Alzheimer’s Phenotypes in 5xFAD Transgenic Mice
by: Yoon Ah Jeong, et al.
Published: (2023-03-01)

Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease
by: In Gyoung Ju, et al.
Published: (2023-02-01)